Anne Marije van Harten is an Investment Director at Apollo Health Ventures, a transatlantic venture capital firm. She leverages her expertise in molecular cell biology and drug development to invest in biotech companies targeting age-related diseases. She earned her PhD in cancer biology from Vrije Universiteit Amsterdam.
She has a strong background in academic research, having worked as a postdoctoral fellow at Thomas Jefferson University and the University of Pennsylvania, focusing on oncology, DNA damage signaling, and targeted therapies.
Interesting fact: She received the Ann and Sol Schreiber Mentored Investigator Award from the Ovarian Cancer Research Alliance (OCRA) for her work on new therapeutic strategies.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.